Spina Bifida Healthcare Navigator Program
ALIGN
1 other identifier
interventional
24
1 country
1
Brief Summary
Many adults with spina bifida experience difficulties managing their health-such as coordinating care across multiple providers, keeping up with medications, and navigating insurance systems. These tasks require strong thinking skills like planning, organizing, and problem-solving, which are often called "executive functions." Many adults with spina bifida have challenges with these skills due to differences in brain development associated with the condition. When a person's thinking abilities do not match the demands placed on them by their healthcare and daily routines, health problems often follow. Despite this, very few programs exist to help adults with spina bifida address this gap. This study tests a new program called ALIGN (Navigating Life with Spina Bifida), developed at the UPMC Adult Spina Bifida Clinic. ALIGN was co-designed with a healthcare provider who is also an adult living with spina bifida. The program helps participants improve the fit between their abilities and their environment through two approaches: building personal skills and strategies, and arranging supports and routines to make demands more manageable. ALIGN includes six virtual group sessions and one individual session with a clinician. Participants will be adults (age 18 or older) with spina bifida. They will complete questionnaires before and after the program measuring confidence in managing health, mood, and ability to participate in daily activities. A separate group of participants who do not take part in ALIGN will complete the same questionnaires for comparison. The main goals are to determine whether ALIGN is practical to deliver, acceptable to participants, and associated with early signs of benefit.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 1, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2026
April 15, 2026
April 1, 2026
4 months
April 1, 2026
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Acceptability of Intervention Measure (AIM)
This measure assesses perceived acceptability of an intervention. The scale consists of 4 items, each rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Scores are calculated as the mean of all items, yielding a score range of 1 to 5. Higher scores indicate greater perceived acceptability. No items are reverse scored.
post-intervention (approximately two months after enrollment; administered only to participants assigned to the intervention group)
Intervention Appropriateness Measure (IAM)
This measure assesses perceived appropriateness of an intervention, defined as its perceived fit, relevance, or compatibility for a given context or population. The scale consists of 4 items, each rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Scores are calculated as the mean of all items, yielding a score range of 1 to 5. Higher scores indicate greater perceived appropriateness. No items are reverse scored.
post-intervention (approximately two months after enrollment; administered only to participants assigned to the intervention group)
Feasibility of Intervention Measure (FIM)
This measure assesses perceived feasibility of implementing an intervention within a given setting. The scale consists of 4 items, each rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). Scores are calculated as the mean of all items, yielding a score range of 1 to 5. Higher scores indicate greater perceived feasibility. No items are reverse scored.
post-intervention (approximately two months after enrollment; administered only to participants assigned to the intervention group)
Secondary Outcomes (10)
Change in PROMIS Depression Measure
Enrollment to approximately two months
Change in Partners in Health (PIH) Scale
Enrollment to approximately two months
Change in Acceptance and Action Questionnaire-2 (AAQ-2)
Enrollment to approximately two months
Change in PROMIS Self-Efficacy (Managing Daily Activities)
Enrollment to approximately two months
Change in PROMIS Participation Measure
Enrollment to approximately two months
- +5 more secondary outcomes
Other Outcomes (2)
Change in Grit-12
Enrollment to approximately two months
Change in Interpersonal Support Evaluation List-12 (ISEL-12)
Enrollment to approximately two months
Study Arms (2)
Intervention
EXPERIMENTALParticipants in this arm will engage in the experimental intervention (ALIGN), which is a six-session, group-based cognitive-behavioral therapy program that is followed by a seventh, individual coaching session with a study clinician. Relevant data will be collected pre-/post-intervention
Control
NO INTERVENTIONParticipants in this arm will participate in a waitlist control condition. Data will collected at a time interval that approximates the intervention arm.
Interventions
The intervention being tested in this study (ALIGN) is designed to improve the fit between an individual's abilities and their environment. This is accomplished through two complementary approaches: building personal skills and strategies ("build"), and arranging supports and routines to make demands more manageable ("scaffold"). ALIGN includes six virtual group sessions and one individual session with a clinician. The intervention fits within the broad umbrella of "third-wave" cognitive-behavioral therapies. It emphasizes psychological flexibility as an important treatment component.
Eligibility Criteria
You may qualify if:
- Adults (18 years or older) diagnosed with spina bifida (SB), including any type (e.g., myelomeningocele, meningocele, lipomyelomeningocele).
- Individuals who are able to participate in educational and interactive sessions (in-person at UPMC Mercy or remotely via secure teleconferencing).
- English fluency
You may not qualify if:
- Under 18 years of age
- Non-English fluency
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- Fisa Foundationcollaborator
Study Sites (1)
University of Pittsburgh/UPMC
Pittsburgh, Pennsylvania, 15219, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ted A Barrios, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 1, 2026
First Posted
April 15, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
August 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
No. This study is a small, pilot, underpowered feasibility project designed to assess acceptability, feasibility, and preliminary signals rather than to support confirmatory hypothesis testing. The sample size and study design limit the reliability and generalizability of individual participant data for secondary analyses, and no formal data-sharing infrastructure or governance plan was established for this pilot. Aggregate results may be disseminated through scholarly publication, but individual participant-level data will not be shared.